General Motors is set to cease the production of its Chevy Bolt electric vehicles this year. This is the company’s first EV unit to be released for the mass market and is currently the best-selling electric car of the brand.
However, General Motors intends to discontinue its Chevy Bolt EVs and move on to another model. The Detroit, Michigan-headquartered automaker is planning to shift to larger EV models, which means electric trucks. The company is planning to use the newest battery technology called the Ultium EV on this project.
As per Fox Business, the Chevy Bolt has prices that start at $26,500, and it is GM’s top-selling unit, accounting for over 90% of the brand’s entire domestic EV sales. The carmaker was said to have sold more than 38,000 Bolt EVs in 2022, and this showed a big increase from the previous record of 24,800. This year, in the first quarter alone, GM already sold 19,700 Chevy Bolts.
In any case, with the end of the Bolt’s production, the plant in Detroit, where it is being built, along with small sports utility vehicles, is set to be converted to allow the manufacturing of GM’s electric GMC trucks and Chevrolet Silverado EVs.
"We have progressed so far that it's now time to plan to end the Chevrolet Bolt EV and EU production, which will happen at the very end of the year," Mary Barra, General Motor’s chief executive officer, told the investors during the earnings call earlier this week.
Meanwhile, General Motors is planning to launch its new small Chevrolet Equinox sports utility vehicle. This electric vehicle has a tag price starting at about $30,000.


BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
China Revises 2024 GDP Lower After Final Review, Eyes Growth in 2025
U.S. Stocks Rally to Record Highs as AI Rebound Fuels Holiday-Shortened Session
Japan Approves Record ¥122.3 Trillion Budget as Takaichi Seeks Fiscal Balance
Russian Stocks End Lower as Energy and Mining Shares Weigh on MOEX Index
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
South Korea Central Bank Warns of Rising Financial Stability Risks Amid Won Volatility
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
Oil Prices Edge Higher as Strong U.S. Growth and Supply Risks Support Market
BOJ Minutes Reveal Growing Debate Over Interest Rate Hikes and Inflation Risks
China to Tighten Crude Steel Output Controls and Export Regulation Through 2030
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing
FDA Approves Mitapivat for Anemia in Thalassemia Patients
Tokyo Core Inflation Stays Above BOJ Target, Strengthening Case for Further Rate Hikes 



